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Functional studies of a chimeric CXCR2/Gai2 protein
Lori Rhoten
The University of Tennessee-Knoxville
Dept. of Biochemistry, Cellular, and Molecular Biology
Abstract:

As transmembrane proteins, chemokine receptors possess a large hydrophobic
portion that is unstable in water and does not fold into the proper conformation in an
aqueous environment. Consequently, it is difficult to isolate these receptor proteins in
order to perform structural studies on them. However, it is believed that a fusion protein
of the receptor connected to the alpha subunit of the G protein would stabilize the Cterminus side of the receptor since the G-protein is soluble in water. Similarly, the
addition of ligand would do the same on the N-terminus side of the protein. This would
increase the solubility of the receptor protein and hopefully confer enough stability to
secure it in its natural confirmation. Here, a fusion protein of the receptor and alpha
subunit is produced. Using transfected HEK 293 cells, the fusion protein is shown to be
expressed on the cell surface.

Introduction:

Chemokines are small, pro-inflammatory protein signals that induce rapid,
directed chemotaxis in phagocytes and T cells toward sites of physical damage by
bacteria, viruses, and other destructive agents4. In addition to increased cell motility,
interaction of chemokines with receptor cells produces changes in cell shape, generation
of superoxide anions, and release of enzymes3 . The result of this is a general
inflammatory response from phagocytic cells followed by a specific immune response
4
from T cells .

The large superfamily of chemokines, approximately 40 proteins, is subdivided
into four groups: C-, CC-, CXC-, and CX3C},4. These divisions are based on differences
in the number and arrangement of the first four conserved cysteine residues in the amino
acid sequence 3. For example, the C-group has only one pair of cysteine residues, while
the other three groups have two pairs 5. Furthermore, the CXC- and CX3C-groups have
cysteine pairs separated by one and three variable amino acids, respectively5.
The activity of chemokines is mediated by their receptors, which are membranespanning G-protein coupled receptors (GPCR). Like other transmembrane proteins, they
have seven alpha-helical transmembrane domains connected by six loops, three
intracellular and three extracellula? The N-terminus is extracellular, binds ligand, is
slightly acidic, and has N-linked glycosylation sites3. Conversely, the C-terminus is
intracellular, interacts with heterotrimeric G-proteins, and has regulatory phosphorylation
sites on threonine and serine residues3. Extracellular loops 1 and 2 are connected by a
disulfide bond between conserved cysteine residues, and intracellular loop 3 may also
interact with the G-proteins2,3.
Upon binding of ligand, a conformational change in the receptor induces an
exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) by the alpha
subunit of the G-protein, leading to dissociation of the alpha subunit from the betagamma subunit complex2 • Exchange of GDP for GTP can be eliminated through a
mutation that replaces an arginine residue with a histidine 1• The beta subunit then
activates phospholipase C, which catalyzes the hydrolysis of phosphotidylinosital-4,5diphosphate (PIP2 ) to inositoll ,4,5-triphosphate (lP3) and diacyl-glycerol (DAG)3. IP3
leads to the release of calcium ions from intracellular strores which then interact with

DAG to activate protein kinase C (PKci. Activation ofPKC leads to phosphorylation of
other proteins and further cellular responses 3 • Simultaneously, the activated alpha
subunit leads to MAP kinase activation and down-regulation of the receptor by
phosphorylation of C-terminus serine and threonine residues3 • Following this, the
chemokine is degraded intracellularly and the activated receptor is returned to the plasma
membrane3 . This desensitization is important in maintaining the ability to sense a
chemical gradiene.
CXCR2 is a chemokine receptor found on granulocytes, monocytes, and mast
cells and on some T cells and natural killer cells3 • Its ligands include interleukin-8 (IL8), one of the most studied chemokines, and all CXC-group chemokines with the Nterminal Glu-Leu-Arg (ELR) motif',4. It is associated with the inhibitory form of the G-

i2i.

protein alpha subunit (G a

Expression ofCXCR2 on neutrophils can be down-

regulated by tumor necrosis factor and lipopolysaccharide and increased by granulocytecolony-stimulating factor 3 •
Methods:

DNA encoding the genes for CXCR2 and Ga i2 were amplified separately using
polymerase chain reaction (PCR) with Ex Taq Polymerase. For CXCR2, the forward and
reverse primers were hCXCR2 Not! (For) (5'GCGGCCGCATGGAAGATTTTAACATGG-3') and hCXCR2-mut (Rev) (5'CTCCCCGGGGAGAGTAGTGGAAGTGTGC-3'), and for Ga i2, they were Smal-Gia2
(Forward) (5' -CCCGGGATGGGCTGCACCGTGAGCGCCG-3' and Gia2-Apal
(Reverse) (5'-GGGGCCCTCAGAAGAGGCCGCAGTCCTT-3'). The products were

run on a 1% agarose gel, and the bands corresponding to 1 kb were extracted using
QIAquick Gel Extraction Kit.
Both CXCR2 and Gai2 DNA were then digested overnight at 37° C with Xmal
restriction enzyme to create complimentary sticky ends at the end of CXCR2 and the
beginning of Gai2. Each was cleaned up with QIAquick PCR Purification Kit, and equal
amounts of DNA from each were ligated with T4 DNA ligase at room temperature
overnight. PCR was then used amplify the ligated DNA using the forward CXCR2
primer and the reverse Gail primer, and the band at 2 kb on a 1% agarose gel was
extracted using QIAquick Gel Extraction Kit. This DNA was ligated into the pEXP5CTITOPO® vector using the Invitrogen TA Expression Kit and used to transform One

Shot® TOP 10 Competent E. coli cells. PCR screening confirmed the presence of the
insert, and plasmid was isolated with Promega's Wizard Plus SV Minipreps DNA
Purification System.
PCR was done on the fusion DNA to introduce a HindIII site at the beginning of
CXCR2 and aXbaI site at the end of Gai2. The forward primer CXCR2 Hind III For was
obtained from Dr. Tom Masi in the Sparer Lab, and the reverse primer was Gia2Xba2
(5'-CTAGTCTAGACTAGTCAGAAGAGG-3'). This DNA was ligated into the same
vector as before and transformed One Shot® TOP 10 Competent E. coli cells. Plasmids
from colonies showing the insert through PCR screening were isolated as before and
digested overnight at 37°C with HindIII and Xbal. Gel extraction isolated the insert,
which was then ligated into the pRc/CMV vector by T4 DNA ligase with a 40: 1 molar
ratio of insert to vector. This reaction was incubated overnight in a water bath at 4°C. 1

~l

of the ligation reaction was then used to transform DH5a cells; colonies were screened

by digestion with HindIII and XbaI.
This plasmid was used to transfect HEK 293 cells. A 6-well dish was plated with
2.0 x 105 cells per well two days before transfecting. GFP was used as a positive control,
and untransfected HEK 293 cells were a negative control. The transfected cells were
harvested from the wells and used for Fluorescent Activated Cell Sorting (F ACS) by
applying a fluorescent antibody specific for CXCR2. Some of the transfected cells were
kept in T150 flasks in complete DMEM media with G418 antibiotic to create a stable line
oftransfectants. These stables were also analyzed by FACS one month after transfection;
and some were frozen in 10% DMSO. Mutagenesis was also performed on the fusion
DNA to introduce the R21 OH mutation in Ga i2. This was done using PCR with Pfu Ultra
Polymerase and primers GaiR210Hl (5'- CAG CGG TCT GAG CAC AAG AAG TGG
ATC -3') and GaiR210H2 (5'- GAT CCA CTT CTT GTG CTC AGA CCG CTG -3') to
change the existing CGG codon to CAC. Both mutant and wild type fusion DNA were
used to transfect HEK 293 cells to create stable cell lines. In collaboration with Dr.
Becker's lab, the wild type CXCR2/Gai2 plasmid is being used to transform yeast cells.

Results:
Sequencing from the Molecular Biology Resource Facility confirmed the

CXCR2/Gai2 insert ligated into the TOPO vector in the correct orientation with CXCR2
proceeding Ga i2. Since the insert was approximately 2 kb, a third primer obtained from
Dr. Sparer's lab was used to sequence the region where the two ligated together. This
confmned neither CXCR2 nor Ga i2 were mutated during ligation. Sequencing also
confirmed the presence of the insert in the correct orientation in the pRc/CMV vector.

Transfection efficiency was done by analyzing GFP fluorescence one day after
transfection. In each case, approximately 80% of the cells transfected showed GFP
expression. For FACS analysis, a gate was set to include only cells which were a certain
size so as to eliminate cell debris from being counted (Figure 1). The first 30,000 cells to
fit this criterion were counted and analyzed. Using the untransfected HEK 293 as
background, approximately 10% and 3% of the transient and stable wild-type
transfectants, respectively, expressed more CXCR2 than normal (Figure 2). By analyzing
fluorescence of antibodies bound to receptors on the cell surface, this confirmed not only
the production of a fusion protein, but also its location on the plasma membrane. FACS
analysis for the mutant CXCR2/G ai2 protein has not yet been performed.

Discussion:
The work presented here provides evidence that a chemokine receptor fused to its
associated G-protein alpha subunit can be expressed on mammalian plasma membranes.
However, more transient cells expressed the fusion protein than observed in the stable
line. This is thought to occur because fusion of the receptor to the G-protein has created
a constitutively active receptor that is down-regulated by the cell. In order to test this
theory, the R21 OH mutation was made to inactivate the fusion G ai2 subunit, but data is
not yet available to confirm or reject this hypothesis. The production of fusion
CXCR2/Gai2 protein on cell surfaces provides opportunity for further experiments to test

its functionality through binding and signaling assays with commercially available
ligands such as IL-8 or gro-a.. Comparison of fusion

K<t and Bmax values to those for

wild-type CXCR2 will show if Ga i2 in some way altered the ability of CXCR2 to bind its
ligands. Observation of calcium flux or other downstream signaling effects, such as

phosphorylation of other proteins, will determine if the fusion protein can still participate
in signal transduction.
For biophysical studies, large quantities of protein are needed, but since CXCR2
is a mammalian protein, this cannot be obtained using a bacterial system such as E. coli.
At first, HEK 293 cells were to be used to isolate the protein, but these proved difficult to
grow in suspension. Media without calcium was used to prevent attachment, but the cells
died, became contaminated, or simply did not grow. Yeast cells, as a eukaryotic system,
can express wild-type CXCR2, so they are to be used produce the fusion protein in large
amounts. The correct plasmid, however, has yet to be produced from the in vivo ligation
reaction of yeast.
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Figure 1: Gated regions for countable cells outlined in black. (a) Transient transfectants
(b) Stable transfectants
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Figure 2: FACS data graphed as fluorescent counts versus number of cells. In both, the
black line is background fluorescence from untransfected 293 cells. (a) Transient cells.
Pink and Green lines are transfections done by Lori and Tom, respectively, at the same
time. Approximatey 10% of transfected cells show more expression than nonnal cells. (b)
Stable cell fluorescence is red line. Only about 3% show more expression.
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